Xuejian Zhao Selected Research

Aldo-Keto Reductase Family 1 Member C3

7/2016	Berberine inhibits androgen synthesis by interaction with aldo-keto reductase 1C3 in 22Rv1 prostate cancer cells.
2/2014	AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xuejian Zhao Research Topics

Disease

13	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 01/2003
12	Neoplasms (Cancer) 01/2018 - 09/2005
3	Melanoma (Melanoma, Malignant) 01/2018 - 03/2013
3	Neoplasm Metastasis (Metastasis) 12/2011 - 06/2007
1	Inflammation (Inflammations) 01/2022
1	Cognitive Dysfunction 01/2022
1	Osteoporosis 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 07/2017
1	Septic Shock (Toxic Shock Syndrome) 01/2015
1	Acute Kidney Injury (Acute Renal Failure) 01/2015
1	Sepsis (Septicemia) 01/2015
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2014
1	Cardiac Conduction System Disease 01/2014
1	Endotoxemia 01/2014
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2013
1	Wounds and Injuries (Trauma) 12/2011
1	Esophageal Squamous Cell Carcinoma 11/2008
1	Carcinogenesis 11/2008
1	Esophageal Neoplasms (Esophageal Cancer) 11/2008
1	Xerostomia 06/2006
1	Hemolysis 12/2005

Drug/Important Bio-Agent (IBA)

9	Small Interfering RNA (siRNA)IBA 07/2017 - 09/2005
5	Prostate-Specific Antigen (Semenogelase)IBA 01/2018 - 01/2003
5	Proteins (Proteins, Gene)FDA Link 07/2017 - 08/2010
4	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 07/2017 - 09/2005
3	AndrogensIBA 07/2016 - 08/2010
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2014
2	Messenger RNA (mRNA)IBA 07/2017 - 09/2005
2	Aldo-Keto Reductase Family 1 Member C3IBA 07/2016 - 02/2014
2	EnzymesIBA 07/2016 - 02/2014
2	graphene oxideIBA 01/2016 - 03/2013
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2015 - 01/2014
2	Urea (Carbamide)FDA LinkGeneric 01/2014 - 12/2005
2	Aquaporins (Water Channels)IBA 01/2014 - 06/2006
1	ipriflavoneIBA 01/2022
1	Caspase 1 (ICE Protease)IBA 01/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2022
1	InterferonsIBA 01/2018
1	Durapatite (Hydroxylapatite)IBA 07/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2017
1	Aldo-Keto ReductasesIBA 07/2016
1	Testosterone (Sustanon)FDA Link 07/2016
1	BerberineIBA 07/2016
1	selenomethylselenocysteine (methylselenocysteine)IBA 06/2015
1	Androgen Receptors (Androgen Receptor)IBA 06/2015
1	panaxadiolIBA 01/2015
1	LipopolysaccharidesIBA 01/2015
1	SaponinsIBA 01/2015
1	Urea TransportersIBA 09/2014
1	Biomarkers (Surrogate Marker)IBA 02/2014
1	Atrial Natriuretic Factor (ANF)IBA 01/2014
1	EndostatinsIBA 06/2013
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 06/2013
1	GraphiteIBA 03/2013
1	PolymersIBA 03/2013
1	PolyethyleneimineIBA 03/2013
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 03/2013
1	human Neu3 proteinIBA 12/2011
1	Selenium CompoundsIBA 08/2010
1	Hormones (Hormone)IBA 08/2010
1	SeleniumIBA 08/2010
1	SurvivinIBA 08/2010
1	beta CateninIBA 11/2008
1	Transcription Factors (Transcription Factor)IBA 06/2007
1	Adenosine Triphosphatases (ATPase)IBA 06/2006
1	SolutionsIBA 12/2005
1	Apoptosis Regulatory ProteinsIBA 09/2005
1	A-Form DNA (A-DNA)IBA 09/2005
1	Cyclin D1IBA 09/2005
1	Biological ProductsIBA 09/2005

Therapy/Procedure

5	Therapeutics 01/2016 - 09/2005
2	Castration 06/2015 - 02/2014
1	Intraperitoneal Injections 01/2014